Skip to main content

Select Drug Profiles

FDA Approvals
Promising New Approaches to Multiple Sclerosis Medications: AAN 2010
Alice Goodman
Read More
Original Research
Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations
Jeff Jianfei Guo, BPharm, PhD, Nick C. Patel, PharmD, PhD, Hong Li, PhD, Paul E. Keck Jr., MD
Stakeholder Perspective
Bipolar Disorder Prevalence Often Underestimated
by Nirav R. Shah, MD,MPH
Read More
Practice Management
Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels
F. Randy Vogenberg, PhD, FASHP
Stakeholder Perspective
The Many Challenges of Pay-for-Performance Programs
by Gary M. Owens, MD
Read More
Practice Management
Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey
Denise Globe, PhD, Peter Mazonson, MD, MBA, Chris Santas, MBA, Regina Murphy, MBA, Annie Cheng, Xingyue Huang, PhD, Arthur Kavanaugh, MD
Stakeholder Perspective
What Is the Value of Specialty Pharmaceuticals?
Read More
FDA Approvals
GI Drugs in Late Development: DDW 2010
Alice Goodman
Read More
FDA Approvals
The Cardiology Pipeline
Wayne Kuznar
Read More
FDA Approvals
Infectious Diseases Pipeline 2009
Alice Goodman
Read More
FDA Approvals
Diabetes Pipeline: New Strategies Emerging for Glycemic Control
Wayne Kuznar
Read More
Page 244 of 244
Results 2431 - 2438 of 2438